For Investors

• Analyst Coverage
• Annual Reports
• Calendar
• Contact Investor Relations
• Financial Reports
• Frequently Asked Questions
• Information Circular
• Management and Investor Relations
• Media Coverage
• News Releases
• Presentations
• Request Documents
• SEDAR Filings
• Stock Quote
• Webcasts
• Why Invest?

News Releases ::

• Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
  More...August 24, 2010
  
• Isotechnika reports second quarter 2010 financial results
  More...August 11, 2010
  
• Lux Biosciences receives Complete Response letter from FDA for voclosporin
  More...August 4, 2010
  

Media Coverage ::

• Pharma Watch: 3SBio, Isotechnika Partner on Voclosporin
  More...August 25, 2010
• Isotechnika lands China deal
  More...August 25, 2010
• Isotechnika Pharma signs $6m commercialization agreement for transplant organ rejection drug with 3SBio in China
  More...August 24, 2010

Events ::

• Annual & Special Meeting
  More...September 9, 2010

Contact Investor Relations

Isotechnika Pharma Inc.
5120 - 75th Street
Edmonton, Alberta
T6E 6W2
Telephone: 780-487-1600
Fax: 780-484-4105
E-mail: Investor Relations

Isotechnika Contact Us